Peter Voorhees, MD
Advertisement
Peter Voorhees, MD, is a member of the Hematology Department at Atrium Health Levine Cancer Institute and a professor of Cancer Medicine at the Wake Forest University School of Medicine in Charlotte, North Carolina.Peter Voorhees, MD
Articles by Peter Voorhees, MD
Advertisement
Latest Updated Articles
Dr. Voorhees on Updated Results of the GRIFFIN Trial in Multiple MyelomaPublished: December 7th 2020 | Updated:
Dr. Voorhees on the Benefit of Monoclonal Antibodies in MyelomaPublished: May 19th 2020 | Updated:
Dr. Voorhees on Pivotal Ongoing Trials in Multiple MyelomaPublished: July 12th 2017 | Updated:
Dr. Voorhees on Managing TRAEs for Patients With Multiple MyelomaPublished: September 6th 2017 | Updated:
Dr. Voorhees on Treatments for Patients With Relapsed Multiple MyelomaPublished: April 28th 2018 | Updated:
Dr. Voorhees Discusses Safety Run-in of Daratumumab in MyelomaPublished: January 12th 2019 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
5